Smith-Lemli-Opitz syndrome is an autosomal recessive disorder caused by mutations of the DHCR7 gene. It is characterized by multiple congenital anomalies and mental retardation.
1. |
Porter JA et al. (1996) Cholesterol modification of hedgehog signaling proteins in animal development. |
2. |
Shefer S et al. (1995) Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. |
3. |
Wassif CA et al. (1998) Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. |
4. |
Fitzky BU et al. (1998) Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. |
5. |
Nowaczyk MJ et al. (1998) Smith-Lemli-Opitz syndrome: phenotypic extreme with minimal clinical findings. |
6. |
Yu H et al. (2000) Detection of a common mutation in the RSH or Smith-Lemli-Opitz syndrome by a PCR-RFLP assay: IVS8-G-->C is found in over sixty percent of US propositi. |
7. |
Yu H et al. (2000) Spectrum of Delta(7)-dehydrocholesterol reductase mutations in patients with the Smith-Lemli-Opitz (RSH) syndrome. |
8. |
Witsch-Baumgartner M et al. (2001) Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: evidence for different origins of common mutations. |
9. |
Wassif CA et al. (2001) Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/SmithLemliOpitz syndrome. |
10. |
Nowaczyk MJ et al. (2001) DHCR7 genotypes of cousins with Smith-Lemli-Opitz syndrome. |
11. |
Nowaczyk MJ et al. (2001) Smith-Lemli-Opitz (RHS) syndrome: holoprosencephaly and homozygous IVS8-1G-->C genotype. |
12. |
Langius FA et al. (2003) Identification of three patients with a very mild form of Smith-Lemli-Opitz syndrome. |
13. |
Kovarova M et al. (2006) Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness. |
14. |
Witsch-Baumgartner M et al. (2008) Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations. |
15. |
Koo G et al. (2010) Discordant phenotype and sterol biochemistry in Smith-Lemli-Opitz syndrome. |
16. |
Kalb S et al. (2012) High frequency of p.Thr93Met in Smith-Lemli-Opitz syndrome patients in Turkey. |
17. |
Witsch-Baumgartner M et al. (2004) Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome. |
18. |
Lazarin GA et al. (2013) An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals. |
19. |
Roux C et al. (1979) Teratogenic action and embryo lethality of AY 9944R. Prevention by a hypercholesterolemia-provoking diet. |
20. |
None (1975) Smith-Lemli-Opitz syndrome: review and report of two affected siblings. |
21. |
Fierro M et al. (1977) Smith-Lemli-Opitz syndrome: neuropathological and ophthalmological observations. |
22. |
Cherstvoy ED et al. () The pathological anatomy of the Smith-Lemli-Opitz syndrome. |
23. |
Fukazawa R et al. () Normal Y sequences in Smith-Lemli-Opitz syndrome with total failure of masculinization. |
24. |
Lachman MF et al. (1991) Brief clinical report: a 46,XY phenotypic female with Smith-Lemli-Opitz syndrome. |
25. |
McKeever PA et al. (1990) Smith-Lemli-Opitz syndrome. II: A disorder of the fetal adrenals? |
26. |
Berry R et al. (1989) Apparent Smith-Lemli-Opitz syndrome and Miller-Dieker syndrome in a family with segregating translocation t(7;17)(q34;p13.1). |
27. |
Chasalow FI et al. () Possible abnormalities of steroid secretion in children with Smith-Lemli-Opitz syndrome and their parents. |
28. |
Bialer MG et al. (1987) Female external genitalia and müllerian duct derivatives in a 46,XY infant with the smith-lemli-Opitz syndrome. |
29. |
Opitz JM et al. (1987) Smith-Lemli-Opitz (RSH) syndrome bibliography. |
30. |
Joseph DB et al. (1987) Genitourinary abnormalities associated with the Smith-Lemli-Opitz syndrome. |
31. |
Scarbrough PR et al. (1986) An additional case of Smith-Lemli-Opitz syndrome in a 46,XY infant with female external genitalia. |
32. |
Curry CJ et al. (1987) Smith-Lemli-Opitz syndrome-type II: multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality. |
33. |
Belmont JW et al. (1987) Two cases of severe lethal Smith-Lemli-Opitz syndrome. |
34. |
Donnai D et al. (1986) The lethal multiple congenital anomaly syndrome of polydactyly, sex reversal, renal hypoplasia, and unilobular lungs. |
35. |
Fried K et al. (1972) Smith-Lemli-Opitz syndrome in an adult. |
36. |
Cotlier E et al. (1971) Cataracts in the Smith-Lemli-Opitz syndrome. |
37. |
Suzuki K et al. (1971) Cellular degeneration in developing central nervous system of rats produced by hypocholesteremic drug AY9944. |
38. |
None (1969) Syndrome of retardation with urogenital and skeletal anomalies (Smith-Lemli-Opitz syndrome): clinical features and mode of inheritance. |
39. |
Deaton JG et al. (1973) Smith-Lemli-Optiz syndrome in a 23-year-old man. |
40. |
Nevo S et al. (1972) Smith-Lemli-Opitz syndrome in an inbred family. |
41. |
Hoefnagel D et al. (1969) The Smith-Lemli-Opitz syndrome in an adult male. |
42. |
Lowry RB et al. (1968) Micrognathia, polydactyly, and cleft palate. |
43. |
Blair HR et al. (1966) A syndrome characterized by mental retardation, short stature, craniofacial dysplasia, and genital anomalies occurring in siblings. |
44. |
Dallaire L et al. (1966) The syndrome of retardation with urogenital and skeletal anomalies in siblings. |
45. |
Kenis H et al. (1967) A familial syndrome of mental retardation in association with multiple congenital anomalies resembling the syndrome of Smith-Lemli-Opitz. |
47. |
Greene C et al. (1984) Smith-Lemli-Opitz syndrome in two 46,XY infants with female external genitalia. |
48. |
None (1983) Brief clinical report: familial neonatally lethal syndrome of hypoplastic left heart, absent pulmonary lobation, polydactyly, and talipes, probably Smith-Lemli-Opitz (RSH) syndrome. |
49. |
None (1983) Editorial comment: variability in the Smith-Lemli-Opitz syndrome: overlap with the Meckel syndrome. |
50. |
Patterson K et al. (1983) Hirschsprung disease in a 46,XY phenotypic infant girl with Smith-Lemli-Opitz syndrome. |
51. |
Tint GS et al. (1995) Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. |
52. |
Opitz JM et al. (1994) Cholesterol metabolism in the RSH/Smith-Lemli-Opitz syndrome: summary of an NICHD conference. |
53. |
Irons M et al. (1993) Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. |
54. |
Alley TL et al. (1995) Identification of a yeast artificial chromosome clone spanning a translocation breakpoint at 7q32.1 in a Smith-Lemli-Opitz syndrome patient. |
55. |
Xu G et al. (1995) Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats. |
56. |
Johnson JA et al. (1994) Prenatal diagnosis of Smith-Lemli-Opitz syndrome, type II. |
57. |
McGaughran J et al. (1994) Diagnosis of Smith-Lemli-Opitz syndrome. |
58. |
Opitz JM et al. (1994) Smith-Lemli-Opitz (RSH) syndrome bibliography: 1964-1993. |
59. |
Irons M et al. (1994) Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient. |
60. |
Wallace M et al. (1994) Smith-Lemli-Opitz syndrome in a female with a de novo, balanced translocation involving 7q32: probable disruption of an SLOS gene. |
61. |
None (1993) Cholesterol defect in Smith-Lemli-Opitz syndrome. |
62. |
Tint GS et al. (1994) Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. |
63. |
Hyett JA et al. (1995) Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome. |
64. |
Dallaire L et al. (1995) Prenatal diagnosis of Smith-Lemli-Opitz syndrome is possible by measurement of 7-dehydrocholesterol in amniotic fluid. |
65. |
Salen G et al. (1996) Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome. |
66. |
De Die-Smulders C et al. (1996) Confirmation of defective cholesterol biosynthesis in 2 previously described adult sibs with Smith-Lemli-Opitz syndrome. |
67. |
Cormier-Daire V et al. (1996) Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz and the lethal acrodysgenital syndromes. |
68. |
Guzzetta V et al. (1996) Clinical and biochemical screening for Smith-Lemli-Opitz syndrome. Italian SLOS Collaborative Group. |
69. |
Seller MJ et al. (1997) Phenotypic diversity in the Smith-Lemli-Opitz syndrome. |
70. |
Pauli RM et al. (1997) Smith-Lemli-Opitz syndrome: thirty-year follow-up of "S" of "RSH" syndrome. |
71. |
Cunniff C et al. (1997) Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism. |
72. |
Alley TL et al. (1997) Physical mapping of the chromosome 7 breakpoint region in an SLOS patient with t(7;20) (q32.1;q13.2). |
73. |
Honda A et al. (1997) Sterol concentrations in cultured Smith-Lemli-Opitz syndrome skin fibroblasts: diagnosis of a biochemically atypical case of the syndrome. |
74. |
Honda A et al. (1997) Screening for abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome: rapid determination of plasma 7-dehydrocholesterol by ultraviolet spectrometry. |
75. |
Ness GC et al. (1997) Increased expression of low-density lipoprotein receptors in a Smith-Lemli-Opitz infant with elevated bilirubin levels. |
76. |
Elias ER et al. (1997) Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS) |
77. |
Irons M et al. (1997) Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trial. |
78. |
Nwokoro NA et al. (1997) Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO/RSH) syndrome. |
79. |
Dehart DB et al. (1997) Pathogenesis of malformations in a rodent model for Smith-Lemli-Opitz syndrome. |
80. |
Irons MB et al. (1998) Prenatal diagnosis of Smith-Lemli-Opitz syndrome. |
81. |
Ryan AK et al. (1998) Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype. |
82. |
None (1998) RSH/Smith-Lemli-Opitz syndrome: mutations and metabolic morphogenesis. |
83. |
Anderson AJ et al. (1998) Variant RSH/Smith-Lemli-Opitz syndrome with atypical sterol metabolism. |
84. |
Atchaneeyasakul LO et al. (1998) Eye findings in 8 children and a spontaneously aborted fetus with RSH/Smith-Lemli-Opitz syndrome. |
85. |
Kratz LE et al. (1999) Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome. |
86. |
Andersson HC et al. (1999) Adrenal insufficiency in Smith-Lemli-Opitz syndrome. |
87. |
Shackleton CH et al. (1999) Equine type estrogens produced by a pregnant woman carrying a Smith-Lemli-Opitz syndrome fetus. |
88. |
Neklason DW et al. (1999) Biochemical variants of Smith-Lemli-Opitz syndrome. |
89. |
Anstey AV et al. (1999) Photosensitivity in the Smith-Lemli-Opitz syndrome: the US experience of a new congenital photosensitivity syndrome. |
90. |
Honda M et al. (2000) Regulation of cholesterol biosynthetic pathway in patients with the Smith-Lemli-Opitz syndrome. |
91. |
Linck LM et al. (2000) Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome. |
92. |
Battaile KP et al. (2001) Carrier frequency of the common mutation IVS8-1G>C in DHCR7 and estimate of the expected incidence of Smith-Lemli-Opitz syndrome. |
93. |
Azurdia RM et al. (2001) Cholesterol supplementation objectively reduces photosensitivity in the Smith-Lemli-Opitz syndrome. |
94. |
Tierney E et al. (2001) Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome. |
95. |
Nowaczyk MJ et al. (2001) Incidence of Smith-Lemli-Opitz syndrome in Ontario, Canada. |
96. |
Nowaczyk MJ et al. (2001) Adrenal insufficiency and hypertension in a newborn infant with Smith-Lemli-Opitz syndrome. |
97. |
None (2003) Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes. |
98. |
WEBER JW et al. (1960) [Typus Rostockiensis Ullrich-Feichtiger. Dyscranio-pygo-phalangia]. |
99. |
SMITH DW et al. (1964) A NEWLY RECOGNIZED SYNDROME OF MULTIPLE CONGENITAL ANOMALIES. |
101. |
Goldenberg A et al. (2004) Antenatal manifestations of Smith-Lemli-Opitz (RSH) syndrome: a retrospective survey of 30 cases. |
102. |
Jezela-Stanek A et al. (2006) Maternal urinary steroid profiles in prenatal diagnosis of Smith-Lemli-Opitz syndrome: first patient series comparing biochemical and molecular studies. |
103. |
Sikora DM et al. (2006) The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. |
104. |
Jiang XS et al. (2010) Activation of Rho GTPases in Smith-Lemli-Opitz syndrome: pathophysiological and clinical implications. |
105. |
OMIM.ORG article Omim 270400 |
106. |
Orphanet article Orphanet ID 818 |
107. |
Wikipedia article Wikipedia EN (Smith–Lemli–Opitz_syndrome) |